Please check your internet connection and try again.
# Ecospirin (Aspirin Enteric-Coated)
## Overview
Ecospirin is an enteric-coated formulation of aspirin, a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory, and antipyretic properties. The enteric coating is designed to delay the release of aspirin until it reaches the small intestine, potentially reducing gastric irritation.
## Primary Indications
* Pain relief (mild to moderate)
* Fever reduction
* Inflammation reduction
* Prevention of cardiovascular events (e.g., myocardial infarction, stroke) in specific patient populations (e.g., secondary prevention, certain primary prevention scenarios). *Note: Use for primary prevention requires careful risk-benefit assessment and is not universally recommended.*
* Rheumatic fever prophylaxis
## Adult Dosing
Dosing varies significantly by indication.
* **Analgesic/Antipyretic:** 325 mg to 650 mg every 4-6 hours as needed. Maximum dose typically 4000 mg per 24 hours.
* **Anti-inflammatory (e.g., rheumatoid arthritis):** 2600 mg to 5400 mg per day, divided into 4-6 doses.
* **Cardiovascular Prevention (Secondary Prevention):** 75 mg to 162 mg once daily.
* **Cardiovascular Prevention (Primary Prevention):** Dosing is controversial and should be individualized. Common doses include 75 mg to 162 mg once daily. *Decision should be made by a healthcare provider.*
## Pediatric Dosing
Aspirin is generally **NOT recommended** for children and teenagers due to the risk of Reye's syndrome, a serious and potentially fatal illness, particularly with viral infections (e.g., influenza, chickenpox).
* **Rheumatic Fever Prophylaxis:** Dosing varies by age and weight and is determined by specific guidelines and physician discretion. For example, doses might range from 10 mg/kg/day to 40 mg/kg/day, divided once or twice daily, with a maximum of 3-4 grams per day.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment, but caution is advised, especially in severe dysfunction, due to potential for accumulation and adverse effects.
## Contraindications
* Known hypersensitivity to aspirin, salicylates, or NSAIDs.
* Asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.
* Active peptic ulceration or gastrointestinal bleeding.
* Use in children and adolescents with viral infections (risk of Reye's syndrome).
* Hemophilia, thrombocytopenia, or other bleeding disorders.
* Severe hepatic or renal impairment.
* Third trimester of pregnancy.
## Adverse Effects
* **Gastrointestinal:** Dyspepsia, heartburn, nausea, vomiting, abdominal pain, occult blood loss, GI ulcers, GI bleeding, perforation.
* **Hematologic:** Increased bleeding time, bruising, petechiae, epistaxis.
* **Hypersensitivity:** Bronchospasm, urticaria, angioedema, rash.
* **Ototoxicity:** Tinnitus, hearing loss (especially at higher doses).
* **Renal:** Renal insufficiency, interstitial nephritis.
* **Hepatic:** Hepatic dysfunction.
* **Reye's Syndrome:** In children and adolescents with viral illness.
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, DOACs):** Increased risk of bleeding.
* **Other NSAIDs and Salicylates:** Additive risk of GI toxicity and bleeding.
* **Corticosteroids:** Increased risk of GI ulcers and bleeding.
* **Antihypertensives (e.g., ACE inhibitors, ARBs, beta-blockers):** NSAIDs may reduce the efficacy of these agents and increase the risk of renal dysfunction.
* **Methotrexate:** Aspirin may increase methotrexate toxicity.
* **Uricosuric agents (e.g., probenecid):** Aspirin may decrease the efficacy of uricosuric agents.
* **Alcohol:** Increased risk of GI bleeding.
## Monitoring
* **Signs and symptoms of GI bleeding:** Melena, hematemesis, abdominal pain.
* **Bleeding:** Monitor for easy bruising, prolonged bleeding from cuts, epistaxis.
* **Renal function:** Especially in patients with pre-existing renal disease or those on concomitant nephrotoxic agents.
* **Hepatic function:** In patients with liver disease or those on long-term therapy.
* **Tinnitus or hearing changes:** May indicate over-adverse effects or toxicity.
## Clinical Pearls
* The enteric coating delays absorption and can reduce peak plasma concentrations compared to non-enteric coated formulations. However, it does not eliminate the risk of GI adverse effects entirely, particularly with long-term use or higher doses.
* For acute pain or fever, immediate-release aspirin may provide faster relief.
* Crushing or chewing enteric-coated aspirin will destroy the coating and increase the risk of gastric irritation.
* Concurrent use of proton pump inhibitors (PPIs) or H2 blockers may be considered to reduce GI risk in patients requiring long-term aspirin therapy, especially those with other GI risk factors.
***
*Disclaimer: This information is intended for educational purposes only and does not constitute medical advice. Always consult the most current prescribing information and a qualified healthcare professional for any questions regarding medication use.*
